Methotrexate + infliximab vs infliximab
Serious adverse events (Schröder 2006) · adult patients with refractory Crohn's disease
It is very uncertain whether methotrexate + infliximab changes serious adverse events (Schröder 2006) compared with infliximab alone (very low certainty).
1 finding from 1 review
- Methotrexate for induction of remission in refractory Crohn's disease 2014 · Cochrane Headline outcomes onlyRR 0.25 [0.01, 5.45]1 study · 19 participantsVery low